May 21, 2025 · Form 4 insider transaction
POON CHRISTINE A bought 3,318 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.; The RSUs will vest in full on May 21, 2026.